Search research articles
Contact Us
Filters
Showing results (621-630 of 641) with videos related to
Page
of 65
Sort By:
Aging
|
March 13, 2021
A COVID-19 risk score combining chest CT radiomics and clinical characteristics to differentiate COVID-19 pneumonia from other viral pneumonias
Zuhua Chen, Xiadong Li, Jiawei Li, et al.
Journal of Viral Hepatitis
|
July 27, 2021
Estimating the transmissibility of hepatitis C: A modelling study in Yichang City, China
Yao Wang, Zeyu Zhao, Hao Zhang, et al.
Journal for Immunotherapy of Cancer
|
December 22, 2021
Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
Yunpeng Yang, Ting Zhou, Xiaozhong Chen, et al.
Oral Oncology
|
February 22, 2024
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
Qiu-Yan Chen, Shan-Shan Guo, Ying Luo, et al.
BMJ Open
|
October 23, 2018
Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2)
Dashan Ai, Yun Chen, Qi Liu, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 5, 2023
Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
Jingjing Miao, Lin Wang, Enya H W Ong, et al.
Signal Transduction and Targeted Therapy
|
June 18, 2024
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Xiaozhong Chen, Wei Wang, Qingfeng Zou, et al.
Lancet (London, England)
|
August 28, 2016
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Li Zhang, Yan Huang, Shaodong Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2021
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
Shaodong Hong, Yaxiong Zhang, Gengsheng Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Radiation Dose-Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy
Ihsuan Tseng, Yun Chen, Dashan Ai, et al.
Page
of 65
Search research articles
Search
Showing results (621-630 of 641) with videos related to
Sort By:
Page
of 65
Aging
|
March 13, 2021
A COVID-19 risk score combining chest CT radiomics and clinical characteristics to differentiate COVID-19 pneumonia from other viral pneumonias
Zuhua Chen, Xiadong Li, Jiawei Li, et al.
Journal of Viral Hepatitis
|
July 27, 2021
Estimating the transmissibility of hepatitis C: A modelling study in Yichang City, China
Yao Wang, Zeyu Zhao, Hao Zhang, et al.
Journal for Immunotherapy of Cancer
|
December 22, 2021
Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
Yunpeng Yang, Ting Zhou, Xiaozhong Chen, et al.
Oral Oncology
|
February 22, 2024
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
Qiu-Yan Chen, Shan-Shan Guo, Ying Luo, et al.
BMJ Open
|
October 23, 2018
Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2)
Dashan Ai, Yun Chen, Qi Liu, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 5, 2023
Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
Jingjing Miao, Lin Wang, Enya H W Ong, et al.
Signal Transduction and Targeted Therapy
|
June 18, 2024
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Xiaozhong Chen, Wei Wang, Qingfeng Zou, et al.
Lancet (London, England)
|
August 28, 2016
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Li Zhang, Yan Huang, Shaodong Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2021
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
Shaodong Hong, Yaxiong Zhang, Gengsheng Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Radiation Dose-Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy
Ihsuan Tseng, Yun Chen, Dashan Ai, et al.
Page
of 65